Literature DB >> 31884527

The function and regulation of OTU deubiquitinases.

Jiansen Du1, Lin Fu1, Yingli Sui1, Lingqiang Zhang2,3.   

Abstract

Post-translational modification of cellular proteins by ubiquitin regulates numerous cellular processes, including cell division, immune responses, and apoptosis. Ubiquitin-mediated control over these processes can be reversed by deubiquitinases (DUBs), which remove ubiquitin from target proteins and depolymerize polyubiquitin chains. Recently, much progress has been made in the DUBs. In humans, the ovarian tumor protease (OTU) subfamily of DUBs includes 16 members, most of which mediate cell signaling cascades. These OTUs show great variation in structure and function, which display a series of mechanistic features. In this review, we provide a comprehensive analysis of current progress in character, structure and function of OTUs, such as the substrate specificity and catalytic activity regulation. Then we discuss the relationship between some diseases and OTUs. Finally, we summarize the structure of viral OTUs and their function in immune escape and viral survival. Despite the challenges, OTUs might provide new therapeutic targets, due to their involvement in key regulatory processes.

Entities:  

Keywords:  OTU deubiquitinases; function; regulation; structure; ubiquitin

Mesh:

Substances:

Year:  2019        PMID: 31884527     DOI: 10.1007/s11684-019-0734-4

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  10 in total

1.  Conformational Dynamics of Deubiquitinase A and Functional Implications.

Authors:  Ashish Kabra; Ying Li
Journal:  Biochemistry       Date:  2021-01-08       Impact factor: 3.162

Review 2.  Modulation of Ubiquitin Signaling in Innate Immune Response by Herpesviruses.

Authors:  Sandrine-M Soh; Yeong-Jun Kim; Hong-Hee Kim; Hye-Ra Lee
Journal:  Int J Mol Sci       Date:  2022-01-01       Impact factor: 5.923

3.  Genome-Wide Identification and Gene Expression Analysis of the OTU DUB Family in Oryza sativa.

Authors:  Qiannan Liu; Tingyun Yan; Xiaoxiang Tan; Zhongyan Wei; Yanjun Li; Zongtao Sun; Hehong Zhang; Jianping Chen
Journal:  Viruses       Date:  2022-02-14       Impact factor: 5.048

4.  OTUD6A promotes prostate tumorigenesis via deubiquitinating Brg1 and AR.

Authors:  Xuhong Fu; Junjie Zhao; Guopeng Yu; Xiaomin Zhang; Jie Sun; Lingmeng Li; Jingyi Yin; Yinan Niu; Shancheng Ren; Yasheng Zhu; Bin Xu; Liyu Huang
Journal:  Commun Biol       Date:  2022-03-01

Review 5.  The Emerging Role of OTUB2 in Diseases: From Cell Signaling Pathway to Physiological Function.

Authors:  Jun Li; Na Zhang; Meihua Li; Tao Hong; Wei Meng; Taohui Ouyang
Journal:  Front Cell Dev Biol       Date:  2022-03-02

6.  Exploring Different Effects of Exclusive Enteral Nutrition (EEN) and Corticosteroids on the Gut Microbiome in Crohn's Disease Based on a Three-Stage Strategy.

Authors:  Dong Guo; Liang Fang; Ruiqing Liu; Yu Li; Liang Lv; Zhaojiao Niu; Dong Chen; Yanbing Zhou; Weiming Zhu
Journal:  Gastroenterol Res Pract       Date:  2022-07-27       Impact factor: 1.919

Review 7.  Regulation of Wnt Signaling through Ubiquitination and Deubiquitination in Cancers.

Authors:  Hong-Beom Park; Ju-Won Kim; Kwang-Hyun Baek
Journal:  Int J Mol Sci       Date:  2020-05-30       Impact factor: 5.923

Review 8.  The structure and function of deubiquitinases: lessons from budding yeast.

Authors:  Harsha Garadi Suresh; Natasha Pascoe; Brenda Andrews
Journal:  Open Biol       Date:  2020-10-21       Impact factor: 6.411

Review 9.  Divergence of Legionella Effectors Reversing Conventional and Unconventional Ubiquitination.

Authors:  Tomoe Kitao; Hiroki Nagai; Tomoko Kubori
Journal:  Front Cell Infect Microbiol       Date:  2020-08-21       Impact factor: 5.293

Review 10.  The Role of E3 Ubiquitin Ligases and Deubiquitinases in Inflammatory Bowel Disease: Friend or Foe?

Authors:  Min Zou; Qi-Shan Zeng; Jiao Nie; Jia-Hui Yang; Zhen-Yi Luo; Hua-Tian Gan
Journal:  Front Immunol       Date:  2021-12-08       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.